Evaluation of the effects of Trigonella foenum graecum seed extract on patients with myocardial infarctio
Phase 2
Recruiting
- Conditions
- Myocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20220516054874N9
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with myocardial infarction according to the American College of Heart criteria
Consent to admission to the study
Age more than 18 years old
Exclusion Criteria
Kidney failure under hemodialysis
Severe liver failure with liver enzymes three times more than normal
History of allergy to Trigonella foenum graecum or peas
History of using medicinal products containing Trigonella foenum graecum seed extract
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in hs-CRP serum level. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.
- Secondary Outcome Measures
Name Time Method Changes in CBC diff. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.;Changes in lipid profile. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.